NantHealth (NASDAQ:NH) Now Covered by

Equities research analysts at began coverage on shares of NantHealth (NASDAQ:NHGet Rating) in a report issued on Wednesday. The brokerage set a “hold” rating on the stock.

NantHealth Price Performance

NH opened at $1.38 on Wednesday. The business has a 50 day simple moving average of $2.03 and a 200-day simple moving average of $2.24. NantHealth has a 12 month low of $1.24 and a 12 month high of $9.75. The stock has a market capitalization of $10.63 million, a P/E ratio of -0.18 and a beta of 1.82.

Institutional Inflows and Outflows

A number of hedge funds have recently added to or reduced their stakes in the stock. Susquehanna International Group LLP acquired a new position in shares of NantHealth during the 1st quarter worth $25,000. Goldman Sachs Group Inc. acquired a new position in NantHealth during the second quarter worth about $36,000. Millennium Management LLC purchased a new stake in shares of NantHealth in the second quarter valued at about $110,000. Finally, Atria Wealth Solutions Inc. grew its position in shares of NantHealth by 117.7% in the second quarter. Atria Wealth Solutions Inc. now owns 491,942 shares of the company’s stock valued at $205,000 after purchasing an additional 265,949 shares during the last quarter. 4.50% of the stock is owned by hedge funds and other institutional investors.

About NantHealth

(Get Rating)

NantHealth, Inc engages in the provision of enterprise solutions that help businesses transform complex data into actionable insights. It is also involved in marketing solutions as a comprehensive integrated solution that includes clinical decision support, payer engagement solutions, data analysis, and network monitoring and management.

Further Reading

Receive News & Ratings for NantHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NantHealth and related companies with's FREE daily email newsletter.